Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 22
1967 29
1968 54
1969 67
1970 71
1971 56
1972 92
1973 92
1974 146
1975 137
1976 147
1977 210
1978 148
1979 181
1980 229
1981 205
1982 200
1983 221
1984 203
1985 202
1986 238
1987 235
1988 215
1989 230
1990 234
1991 278
1992 220
1993 201
1994 195
1995 176
1996 253
1997 162
1998 196
1999 197
2000 208
2001 208
2002 246
2003 233
2004 241
2005 282
2006 283
2007 287
2008 247
2009 323
2010 285
2011 359
2012 286
2013 243
2014 273
2015 233
2016 187
2017 183
2018 147
2019 72
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10,064 results
Results by year
Filters applied: . Clear all
Page 1
Mineral metabolism and bone abnormalities in children with chronic renal failure.
Sanchez CP. Rev Endocr Metab Disord 2008 - Review. PMID 18175221
Abnormalities in mineral metabolism and changes in skeletal histology may contribute to growth impairment in children with chronic renal failure. ...The recent KDIGO conference has made recommendations to consider this as a systemic disorder (chronic kidney disease-mineral bone disorder) and to standardize bone histomorphometry to include bone turnover, mineralization and volume (TMV). ...
Abnormalities in mineral metabolism and changes in skeletal histology may contribute to growth impairment in children with chronic
Mechanisms and consequences of carbamoylation
Delanghe S, et al. Nat Rev Nephrol 2017 - Review. PMID 28757635
Carbamoylated proteins have been linked to atherosclerosis, lipid metabolism, immune system dysfunction (such as inhibition of the classical complement pathway, inhibition of complement-dependent rituximab cytotoxicity, reduced oxidative neutrophil burst, and the formation of anti-carbamoylated protein antibodies) and renal fibrosis. ...We also discuss the relationship between carbamoylation and the occurrence of cardiovascular events and mortality in patients with chronic kidney disease and assess the effects of strategies to lower the carbamoylation load....
Carbamoylated proteins have been linked to atherosclerosis, lipid metabolism, immune system dysfunction (such as inhibition of the cl …
Drug metabolism in chronic renal failure.
Pichette V and Leblond FA. Curr Drug Metab 2003 - Review. PMID 12678690
Although the mechanism by which this occurs is unclear, several studies have shown that CRF affects the metabolism of drugs by inhibiting key enzymatic systems in the liver, intestine and kidney. ...CRF will lead to a decrease in the ability of the kidney to metabolize drugs, but the repercussions on the systemic clearance of drugs is still poorly defined, except for selected xenobiotics. ...
Although the mechanism by which this occurs is unclear, several studies have shown that CRF affects the metabolism of drugs by inhibi …
The effect of chronic renal failure on hepatic drug metabolism and drug disposition.
Dreisbach AW and Lertora JJ. Semin Dial 2003 - Review. PMID 12535300
There is abundant evidence that chronic renal failure (CRF) and end-stage renal disease (ESRD) alter drug disposition by affecting protein and tissue binding and reducing systemic clearance of renally cleared drugs. ...This review includes all significant animal and clinical studies using the search terms "chronic renal failure,""cytochrome P-450," and "liver metabolism" over the past 10 years obtained from the National Library of Medicine MEDLINE database, including relevant articles back to 1969....
There is abundant evidence that chronic renal failure (CRF) and end-stage renal disease (ESRD) alter drug disposition by affec …
Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal.
Rubenfeld S and Garber AJ. J Clin Invest 1978. PMID 659634 Free PMC article.
To delineate the potential role of disordered glucose and glucose-precursor kinetics in the abnormal carbohydrate metabolism of chronic renal failure, alanine and glucose production and utilization and gluconeogenesis from alanine were studied in patients with chronic compensated renal insufficiency and in normal volunteers. ...In 13 patients with chronic renal failure (creatinine = 10.7+/-1.2 mg/100 ml; mean+/-SEM), glucose turnover was found to be 1,035+/-99.3 mumol/min. ...
To delineate the potential role of disordered glucose and glucose-precursor kinetics in the abnormal carbohydrate metabolism of ch
New insights into lipid metabolism in chronic kidney disease.
Kaysen GA. J Ren Nutr 2011 - Review. PMID 21195934
Disorders in lipid levels in kidney disease consist of alterations both in the levels of the differing lipoprotein classes as well as alteration in their structures. ...
Disorders in lipid levels in kidney disease consist of alterations both in the levels of the differing lipoprotein classes as well as …
Urea metabolism in chronic renal failure.
Walser M. J Clin Invest 1974. PMID 4825230 Free PMC article.
Urea degradation was measured during 16 experiments in 13 chronic uremic patients being treated with essential amino acids or their analogues. [(14)C]Urea was injected i.v. and the clearance of labeled urea from its volume of distribution was compared with the simultaneous renal clearance of ordinary urea, which averaged 2.0 liters/day. ...
Urea degradation was measured during 16 experiments in 13 chronic uremic patients being treated with essential amino acids or their a …
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure.
Emmett M. Kidney Int Suppl 2004 - Review. PMID 15296504
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Over the past 30 years it has become apparent that hyperphosphatemia plays a major causative role across the entire spectrum of morbidity associated with advancing kidney dysfunction and failure. ...After initiation of chronic dialysis therapy, the absorbed phosphorus load should match the amount of phosphorus removed via dialysis plus any excreted by residual kidney function. ...
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Over the past 30 years i …
10,064 results
Jump to page
Feedback